GTLS vs REGN · rev $4.16B vs P/E 14, rev $4.29B
Chart Industries Inc (GTLS) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Chart Industries Inc (GTLS) is a specialty industrial machinery company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported GTLS revenue for 2024-12-31 was $4.16B. Net income was $232.8M. Revenue was up 24.1% from 2023-12-31 to 2024-12-31. GTLS currently screens at market cap $9.90B.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
GTLS currently screens at market cap $9.90B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the GTLS and REGN stock pages for the full models.
Not investment advice.